Evidence map›Paper›PMID 33247190›Full record

ArticleCommunications biology2020

Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells.

Leigh A Stoddart, Nicholas D Kindon, Omolade Otun, Clare R Harwood, Foteini Patera, Dmitry B Veprintsev, Jeanette Woolard, Stephen J Briddon, Hester A Franks, Stephen J Hill and 1 more

Abstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Dual blockade of adenosine AFrontiers in immunology · 2026
    Article
  5. Article
  6. Bitopic AJournal of medicinal chemistry · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Ligand-Directed Labeling of the Adenosine AJournal of medicinal chemistry · 2024
    Article
  16. ACS chemical biology · 2024
    Article
  17. Review
  18. Fluorescent APurinergic signalling · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leigh A StoddartCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-4469-0600
Nicholas D KindonCentre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Nottingham, Midlands, NG7 2RD, UK.
Omolade OtunCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.
Clare R HarwoodCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0003-1403-3666
Foteini PateraDivision of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK.
Dmitry B VeprintsevCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-3583-5409
Jeanette WoolardCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.
Stephen J BriddonCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0001-8514-0827
Hester A FranksCentre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Nottingham, Midlands, NG7 2RD, UK.ORCID 0000-0001-5378-6076
Stephen J HillCell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, NG7 2RD, UK. stephen.hill@nottingham.ac.uk.ORCID 0000-0002-4424-239X
Barrie KellamCentre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Nottingham, Midlands, NG7 2RD, UK. barrie.kellam@nottingham.ac.uk.ORCID 0000-0003-0030-9908

Funding

Cancer Research UK 24952Department of HealthMedical Research Council MR/N020081/1
6 · The paper itself

Abstract

To study the localisation of G protein-coupled receptors (GPCR) in their native cellular environment requires their visualisation through fluorescent labelling. To overcome the requirement for genetic modification of the receptor or the limitations of dissociable fluorescent ligands, here we describe rational design of a compound that covalently and selectively labels a GPCR in living cells with a fluorescent moiety. We designed a fluorescent antagonist, in which the linker incorporated between pharmacophore (ZM241385) and fluorophore (sulfo-cyanine5) is able to facilitate covalent linking of the fluorophore to the adenosine A

Indexed as

Fluorescent DyesTriazinesTriazolesAffinity LabelsDrug DesignHEK293 CellsHumansLigandsReceptor, Adenosine A2AReceptors, G-Protein-CoupledADORA2A protein, humanAffinity LabelsFluorescent DyesLigandsReceptor, Adenosine A2AReceptors, G-Protein-CoupledTriazinesTriazolesZM 241385

Identifiers

PMID33247190
PMCPMC7695831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.